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Abstract
Background: The tumor suppressor protein p53 is regulated by the ubiquitin ligase MDM2 which
down-regulates p53. In tumours with overexpressed MDM2, the p53-MDM2 interaction can be
interrupted by a peptide or small molecule to stabilize p53 as a therapeutic strategy. Structural and
biochemical/mutagenesis data show that p53 has 3 hydrophobic residues F19, W23 and L26 that
embed into the ligand binding pocket of MDM2 which is highly plastic in nature and can modulate its
size to accommodate a variety of ligands. This binding pocket is primarily dependent on the
orientation of a particular residue, Y100. We have studied the role of the dynamics of Y100 in p53
recognition.
Results: Molecular dynamics simulations sho wt h a tt h eY 1 0 0s i d ec h a i nc a nb ei n“open" or
“closed" states with only the former enabling complex formation. When both p53 and MDM2 are
in near native conformations, complex formation is rapid and is driven by the formation of a
hydrogen bond between W23 of p53 and L54 of MDM2 or by the embedding of F19 of p53 into
MDM2. The transition of Y100 from “closed" to “open" can increase the size of the binding site.
Interconversions between these two states can be induced by the N-terminal region of MDM2 or
by the conformations of the p53 peptides.
Conclusion: Molecular dynamics simulations have revealed how the binding of p53 to MDM2 is
modulated by the conformational mobility of Y100 which is the gatekeeper residue in MDM2. The
mobility of this residue can be modulated by the conformations of p53 and the Nterminal lid region
of MDM2.
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The tumor suppressing activity of the protein p53 is
down-regulated by the ubiquitin ligase MDM2 which
complexes p53 and targets it for degradation [1]. In
normal cells the p53 protein, which also is a transcrip-
tion factor active at the MDM2 promoter, is maintained
at low levels through this negative feedback loop. In
damaged cells the MDM2-p53 complex is destabilized
through posttranslational modifications, e.g. phosphor-
ylation. This disrupts the complex, frees p53 which then
activates the repair or apoptotic pathways [1]. This has
spawned several studies aimed at to the development of
peptides/small molecules that can displace p53 from its
complex with MDM2 [2-6]. The structural data on the
MDM2-ligand complexes available in Protein Data Bank
(PDB) show a wide structural variation amongst the
several MDM2-inhibitor complexes. These reveal a
highly plastic nature of the binding pocket of MDM2
(Figure 1). The significance of this plasticity in inhibitor
design has been addressed in recent studies [7,8]. One
residue that has been found to play a major role in
modulating this plasticity through the size of the binding
pocket is Y100 [7,9]. The orientation of the Y100 side
chain controls the size of the binding pocket and also
contributes to the stabilization of the ligands in the
complex by enabling stable interactions. Both, the crystal
structure (PDB code 1YCR) [10] and molecular dynamics
(MD) simulations of the complex of MDM2 and a 13
residue fragment of the transactivation domain of p53
show that Y100 points away from the binding pocket
and forms a hydrogen bond (HB) with either the
backbones of E28 or N29 of wild type (WT) p53 peptide.
This stabilizes an unstructured C-terminal region of the
peptide that lies outside the binding pocket [7]. In
addition, there are conformational states with small
molecules/peptides bound where Y100 'points in'
towards the binding pocket and stabilizes the complex
with a different set of interactions [7]. Recently, it was
reported from biochemical measurements that the P27S
mutant of p53 has a higher affinity for MDM2 than wild
type p53. Simulations revealed that in the complex, the
peptide adopts an a-helical conformation at the
C-terminus (which is unstructured in the WT p53) and a
r e a r r a n g e m e n to ft h en e t w o r ko fi n t e r a c t i o n so c c u r s .
There is a dramatic change of the MDM2 surface which is
caused by the reorientations of the L54 and Y100 side
chains. The flip of the latter towards the binding pocket
organizes a cozier fit of the ligand and stabilizes an HB
with the L26 backbone, suggesting an induced fit
mechanism of peptide binding [7].
On the other hand, the apo state of MDM2 as evidenced
by the ensemble of NMR structures (PDB code 1Z1M)
[8] shows that Y100 sits in a deeply buried position (see
Figure 2) which is remarkably different from that in its
complexed state. This suggests a possible coupling of the
dynamics of Y100 with the binding of p53. Interest has
recently been focused on the differences between pre-
organized binding/conformational selection (where for
example the p53 peptide chooses a conformation of
MDM2 from an ensemble, that is optimal to bind that
peptide) or induced binding (for example the p53
peptide binds in some conformation to MDM2, and
the complex then undergoes conformational rearrange-
ments that maximizes the interactions) [11]. To inves-
tigate this we have carried out a series of molecular
dynamics simulations of systems containing MDM2 and
p53 in various states. The main focus is on investigating
the changes that take place in p53 and in MDM2 as they
approach each other. A somewhat similar investigation
but with coarse graining simulations has recently been
reported [12]. The study shows the conformational
changes associated with the transition from uncom-
plexed (apo) state to the complexed states of MDM2
which leads to the diverse conformational states of
MDM2.
We have used molecular dynamics simulations to
examine three different conformations of MDM2: (i)
'Open' state of the conformation taken from the wild
1YCR 2AXI 1RV1
2GV2 1T4F 3EQS
Y100
Figure 1
MDM2 in surface representation, taken from various
structures available in PDB, complexed with various
ligands including WT p53 (1YCR), a b-hairpin peptide
(2AXI), small molecule 'nutlin' (1RV1), an 8-mer p53
peptide analogue (2GV2), an optimized peptide
(1T4F) and a 12 residue peptide. PDB codes have been
mentioned at the right bottom of each structure. The
location of Y100 on the surface has been mentioned for the
WT structure. The surface was colored according to the
charges of the surface residues: positive (blue), negative (red)
and neutral (white).
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pointing away from the binding pocket; (ii) 'closed' state
- the conformation of MDM2 taken from the complex
with a-helical P27S mutant of p53 with the Y100 side
chain pointing towards the binding pocket; (iii) The
'apo' state - the unliganded state of MDM2, obtained
from the ensemble of NMR structures [8] where Y100 is
in a deeply buried position (see Figure 2).
Other approaches to investigate such phenomena are
Brownian Dynamics simulations [13], Replica Exchange
methods [14-17] and the more recently developed
accelerated molecular dynamics methods [18]. While
the Brownian dynamics methods are well suited for
studying protein-protein associations where proteins are
depicted in a reduced representation [19], the replica
exchange methods can be used to examine pathways of
folding [16]; the accelerated molecular dynamics meth-
ods have been very successful in examining long time
scale processes [18]. In this study, we are attempting to
understand atomic level details of the process prior to
the embedding of p53 into MDM2. Aspects of this
process involve a coupling between folding and binding,
at least of the p53 peptide [20]. We have chosen to run
classical molecular dynamics simulations with several
different starting conditions and as will be seen, these
capture local folding/unfolding events through extensive
surface rearrangements. A major factor that limits the
usage of replica exchange methods here is that the
current system is comprised of around 100 amino acids
and replica exchange methods, particularly in explicit
solvent, can only meaningfully (exhaustively) be applied
to peptides that are up to 40 amino acids long [21-24]
and hence are not suitable for the sort of extensive
surface rearrangements that we sample here. Moreover,
the MDM2 binding site is highly hydrophobic and there
is the possibility that it will rapidly unfold in the REMD
methods. For the same reason, the accelerated molecular
dynamics method was not used.
Results
We first outline briefly the currently accepted picture of
the mechanism of interaction between p53 and MDM2
in their bound state. Crystallographic, biophysical and
computational studies have traditionally shown that
F19, W23 and L26 are the three critical residues of the
t r a n s a c t i v a t i o nd o m a i n( T A )o fp 5 3w h i c hl a r g e l y
determine the stability of its complex with MDM2
[10,25]. The residues F19 to L25 form an a-helical
segment which has a hydrophobic face that subtends the
side chains of the three hydrophobic residues F19, W23
and L26 which get embedded in the binding pocket of
MDM2. In addition to the hydrophobic interactions
between these 3 residues and MDM2, the W23 side chain
also makes an HB with the backbone of L54 of MDM2,
and this is very critical for the stability of the complex
[7,26]. More recently, it has been demonstrated that
other parts of both p53 and MDM2 are involved in
modulating these interactions [7,12,27]. One residue
whose dynamics appear to potentiate this binding is
Y100 of MDM2 which “gates" the conformation of the
p53 peptide. This residue is conserved across species (see
Supporing Information in [7]). If the p53 peptide is
extended at its C-terminus (as seen in the crystal
structure 1YCR), the side chain hydroxyl of Y100 is
involved in hydrogen bond (HB) with the backbone of
either E28 or N29 of the p53 peptide; however the p53
peptide can also adopt an a-helical conformation at its
C-terminus and this is potentiated by the Y100 hydroxyl
forming an HB with the backbone of L26 which provides
a 'cozier' fit between the p53 peptide and MDM2 [7]. We
set out to investigate the mechanism that governs the
d e v e l o p m e n to ft h e s ei n t e r a c t i o n sa sp 5 3a p p r o a c h e s
MDM2; we are particularly interested in examining the
modulation of the conformational activity of Y100.
Recently, a study has investigated such a process using
targeted simulations of the binding pathway under a
H96
Y100
L54
Figure 2
Superimposed structures of 'open' (salmon red),
'closed' (yellow) and 'apo' (purple) states of MDM2.
The residues L54, H96 and Y100 have been shown in sticks
for all conformations and the residue names have been
labeled for the apo-state. The Y100 is deeply buried in the
apo-state.
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examine the process of binding, without directing the
binding, and in an all-atom model with explicit
solvation. The steady behavior of the root mean squared
deviations (RMSD) of MDM2 in the various situations
shows that the simulations are stable (see Figure S1 in
Additional File 1).
p53 and 'open' MDM2
When p53 approaches the 'open' state of MDM2 from a
distance of 3 Å, (trajectory: Mo3A, see Table 1), complex
formation is rapid and the crystallographically observed
stateisreachedwithmostoftheinteractionsreportedabove
reproduced. The W23-L54 HB forms within 300 ps. The
Y100-E28 hbond takes somewhat longer (~2 ns) to form.
Indeed, the complex is stabilized by 10 ns, which suggests
that preorganization of the partners into 'reactive' con-
formations leads to rapid complex formation (Figure 3 and
Additional File 2). This of course was enabled because we
started with the crystal structure conformations (which are
the preorganized conformations). This is in accord with the
models proposed and observed in other simulations for
protein-protein interactions [12,28]. Moreover, the
enthalpy of binding close to what has been reported
elsewhere using the crystal structure of the complex (ΔH~-
56.6 kcal/mol here compared to -54.7 kcal/mol, [7]); the
difference is expected due to the different starting states.
Indeeditishearteningtoseethesimilarityofthetwovalues,
suggestive of a real productive encounter between p53 and
MDM2 starting 3 Å apart. Interestingly Y104, the residue
spatially contiguous to Y100 undergoes side chain mobi-
lities that are larger in magnitude to those in Y100 and yet
are correlated with it (Figure S2 in Additional file 1).
In contrast, when p53 approaches the “open" state of
MDM2 from a separation of ~6 Å (Trajectory Mo6A), it
manages to reach the surface of MDM2 in the vicinity of
the binding pocket (Figure S1 in Additional File 1)
within 0.5 ns. However the interactions are nonspecific
and p53 never manages to embed into MDM2 com-
pletely. The fact that it reaches the surface originates in
the long range electrostatic fields that will no doubt steer
the two molecules [29]. The W23 side chain forms
interactions with the side chain of F55 which appears to
displace p53 to a position slightly away from its native
(or crysatllographically observed) location. At the same
time, Y100 flips in towards the binding pocket; this
presumably happens to minimize the exposure to
Table 1: List of trajectories
Trajectory name MDM2 p53 Length
1M o 3 A o p e n R M S D 3 Å1 0 n s
2M o 6 A o p e n R M S D 6 Å1 0 n s
3M c 3 A T 1 c l o s e d R M S D 3 Å2 0 n s
4M c 3 A T 2 c l o s e d R M S D 3 Å2 0 n s
5M c 6 A C l o s e d R M S D 6 Å4 0 n s
6 Mc6A7ns simulation started from the snapshot taken at 7.5 ns of Mc6A 25 ns
7 M1n4A Apo, model 1 RMSD 4 Å 20 ns
8 M1n6A Apo, model 1 RMSD 6 Å 10 ns
9 M1n4AWT Taken from M1n4A at the end of 20 ns RMSD ~6 Å 5 ns
10 M1n Apo, model 1 NIL 20 ns
11 M2n119 Apo, model 2 (Residue 1-119) NIL 15 ns
12 M4n119 Apo, model 4 (Residue 1-119) NIL 10 ns
The source of the coordinates of the structures has been reported in the text. The RMSD corresponds to the p53 backbone in the starting structures
of the simulations, after superimposing the MDM2 of the on the crystal structure of the MDM2-p53 complex
E28
Y100
K51
L54
W23
F19
Y100
(a) (b)
(c)
L26
F55
Y100
(d)
K51
Y100
W23
L26
W23
L54
Figure 3
(a),(b) Snapshots taken at the end of 10 ns simulation
of Mo3A (See Table 1). MDM2 (green) has been shown in
ribbon in 'a' and surface representations in 'b'; and p53 (red)
has been shown in ribbon. The HB between residue pairs
W23-L54, E28-Y100 and the polar interaction between the
side chains of E28 and K51 have been shown with dashed
(black) line in the picture 'a'. (c),(d) Snapshot taken at he end
of Mc3A trajectory (See Table 1)
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Again the mobility of Y104 is correlated with that of
Y100 (Figure S2 in Additional File 1).
p53 and 'closed' MDM2
We next examine the approach of p53 towards MDM2
when the latter is in its 'closed' state. F19 and W23 find
their crystallographically observed positions (trajectory
Mc3AT1, Table 1) within 0.5 ns, but L26 is obstructed by
Y100 which points into the binding pocket (this being
the 'closed' state of MDM2). The HB between the W23
side chain and the L54 backbone is transiently stable
because the W23 is prevented from approaching
sufficiently close to MDM2 (Figure 4 and Additional
File 3). This is because of competition between the W23
side chain and the Y100 side chain for Hbonding with
the backbone of L54 and also because the surface of
MDM2, as defined by an inward-pointing Y100,
occludes p53. Eventually L26 is “kicked out" by Y100
(See Movie in Additional File 3). In the trajectory
Mc3AT1 Y100 is further forced to remain in its closed
conformation by the extended C-terminus of the p53
peptide. To further probe the effect of the restraint
imposed upon Y100, we modified the initial conforma-
tion of the C-terminus of p53. The backbone conforma-
tions of residues 27-28 were changed in a manner that
released the spatial constraint upon Y100. Now we
observe (trajectory Mc3AT2) that Y100 flips out after just
a few nanoseconds and in turn enables p53 to nicely fit
into the binding pocket of MDM2, in a conformation
resembling that of the WT crystal structure (Figure 4 and
Additional File 4); this clearly highlights the effect of the
C-terminal region of p53 on modulating the gating of
Y100 of MDM2. The mobility of Y104 is correlated
strongly with that of Y100; interestingly, when no
binding takes place, the magnitude of fluctuations of
both side chains are similar, while upon binding events,
the mobility of Y104 is correlated with that of Y100 but
the magnitude is larger (Figure S2).
When p53 was placed 6 Å away from the binding pocket
of MDM2 (trajectory Mc6A), again, as seen in the “open"
state described above, p53 reaches the surface of MDM2
in the vicnity of the binding pocket within 0.5 ns. In
contrast to the “open" state, here Y100 flips out to fully
open the binding pocket. Even as F19 attempts to dock,
it provides an anchor that enables W23 and L26 to move
towards their binding pockets. However, local collisions
induce a rotation in the W23 side chain away from the
orientation optimal for its binding. This results in p53
moving away from the surface of MDM2 and the W23
side chain adopts a stacking interaction with F55 of
MDM2. (Figure 5 and Additional Files 5, 6, 7). We
extracted a structure of the p53-MDM2 complex from
L54
L26
Y100
(a)
Y100
(b)
(c) (d)
Y100
L26
Y100
Figure 4
(a),(b) Snapshot at the end of 20 ns simulation of
Mc3AT1. Y100 stays in a 'flipped-in' conformation and L26
of p53 (red) is out of the binding pocket, F19 and W23 fits
into their crystallographically observed position and W23
and L54 forms HB; (c),(d) Snapshots at the end of 20 ns
simulation of Mc3AT2. F19, W23 and L26 are fitted into the
binding pocket of MDM2. Critical H-bond between W23 and
L54 is marked with dashed line. Figures in the same row
represent the same structure but differ in ribbon and surface
representations of MDM2 (green).
(a) (b)
Y100
L26
F55
W23
L26
Hbond
Figure 5
(a) Snapshots taken at the end of 20 ns simulation of
Mc6A. W23 of p53 (red) is out of the binding pocket. (b)
Snapshot taken at the end of 22 ns of the simulation of the
trajectory Mc6A7ns, showing the crystallographically
observed binding mode of the side chains F19, W23 and L26
and W23-L54 HB is formed.
BMC Bioinformatics 2009, 10(Suppl 15):S6 http://www.biomedcentral.com/1471-2105/10/S15/S6
Page 5 of 11
(page number not for citation purposes)this trajectory which whose conformation had the lowest
deviation from the crystallographic complex (RMSD ~4
Å), and that had Y100 pointing “out"; this was subject to
an MD simulation (Trajectory Mc6A7ns). This structure
forms the crystallographically observed interactions in
less than a nanosecond, including the W23-L54 HB
( F i g u r e5 ba n dm o v i eA d d i t i o n a lF i l e7 ) .A g a i nY 1 0 4
mobility is correlated with that of Y100 (Figure S2 in
Additional File 1). Here we see some evidence of the
presence of an intrinsic harmonicity with open-closed
states of the Y100 appearing at a timescale of ~3-4 ns.
p53 and 'apo' MDM2
Thus far we have used the complexed state of p53-
MDM2 determined crystallographically to seed the
starting conformations of our various investigations.
Given that the structure of MDM2 is available in its
uncomplexed or “apo" state from NMR [8], we decided
t ou s et h i sa so u rs t a r t i n gs t a t ef o rM D M 2 .I na l lt h e2 4
conformations of MDM2 available, the Tyr100 points
inwards; this is expected as this minimizes the exposure
of the very hydrophobic binding pocket of MDM2 and
also enables the HB between the backbone of Leu54 and
the side chain hydroxyl of Tyr100. When p53 was placed
near the binding pocket of MDM2 (trajectory M1n4A),
surprisingly p53 loses its helicity. This appears to be due
to the fact that the side chains of MDM2 in this NMR-
derived state are not optimally located to interact with
p53 (which the crystallographic state does). However, as
the system explores the conformational states, we soon
observe that MDM2 interacts with W23 and F19 of p53
and its binding pocket is induced to open (Figure 6).
Although this does not lead to the crystallographically
observed state of the complex, W23 and F19 do embed
in the binding pocket which leads to stabilization of the
hydrophobic pocket of MDM2. F19 gets packed by
several hydrophobic residues including I61, V75, F91,
V93 and F86 (Figure 6c). The interesting observation is
that although the orientation of the side chains of F19
and W23 change to a non native conformation, we do
not see dissociation of the complex. It appears that at the
initial stage of complex formation, helical conforma-
tions of p53 can initiate complex formation that can be
seeded by an initial insertion of F19 into the hydro-
phobic pocket. This in turn is complemented by some
expansion of the overall pocket of MDM2 that enables
W23 to get embedded (See Movies in Additional Files 8).
To examine these later stages of binding we take the last
( a tat i m eo f2 0n s )s n a p s h o to ft h ea b o v et r a j e c t o r ya n d
replace p53 (which has been somewhat distorted
conformationally from its native bound conformation)
by p53 taken from the crystal structure. We find that
despite p53 being in its optimal conformation, in these
simulations Y100 (which points in toward the binding
pocket) does not enable p53 to embed and indeed
pushes it away. In addition, the side chains of H96 and
R97 obstruct the C-terminus of p53. Once again, Y100 is
constrained by the presence of the C-terminal end of the
TA of p53 (as we saw earlier in the case of p53 at 3 Å
from the closed state) and cannot flip out to create space
for W23 to embed. This indicates that prior to the
binding of p53, the opening of the hydrophobic pocket
of MDM2 by transition of Y100 to its 'open' conforma-
tion appears to be a key step to facilitate this binding.
The interesting feature is that the mobility of Y104 is
now dependant upon the position of the lid. The movies
in the additional files 9, 10, 11 show that that once the
lid opens, Y100 goes into an open state but Y104 is still
constrained by the lid and does not open.
Discussion
The TA of p53 is known to be largely intrinsically
disordered with some parts of it adopting a helical
conformation upon binding to MDM2. This brings three
side chains (F19, W23 and L26) of p53 to be displayed
o nt h es a m ef a c eo ft h eh e l i xt h u se n a b l i n gt h e mt o
embed into a hydrophobic binding pocket of MDM2.
Experimental data show that the unliganded state or the
apo-state of MDM2 (derived using NMR, [8]) is quite
different from its complexed state (derived using crystal-
lography, [10]). What is not understood well is the
process of binding of p53 and MDM2 to each other,
mediated by these conformational states: is it pre-
organization prior to binding or is it reorganization
after binding (or induced fit). To test these, we have
carried out a series of MD simulations that mimic the
approach of p53 to MDM2. We avoided the simulation
of folding/unfolding transitions of p53 during the
simulations [20] and assumed that when p53 is very
close to MDM2, stereo-chemical constraints would
demand that the helical conformation of p53 be
dominant in its interactions. We have mostly focused
on the plasticity of MDM2 and the dynamics of Y100.
The structural data shows that the plasticity of the
binding pocket of MDM2 is mainly determined by the
orientation of Y100 (Figures 1, 2), with spatially
contiguous Y104 correlated with Y100 in mobility.
When p53 is in its native (or crystallographically
observed) state and MDM2 is “open", binding occurs
with only small local reorganizations as side chains
reorient minimally to maximize interactions. The size of
the binding site, as determined from the solvent
accessible surface area (data not shown) varies from
~2250 Å
2 to ~2450 Å
2 as the MDM2 transits from a
relatively closed apo state to the p53 bound state. The
general fluctuations of MDM2 (Figure S3 in Additional
File 1) are conserved in pattern across the various
BMC Bioinformatics 2009, 10(Suppl 15):S6 http://www.biomedcentral.com/1471-2105/10/S15/S6
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standable because the peptide and MDM2 modulate
each other and this will certainly change depending on
their relative orientations, with the largest mobility
witnessed in the presence of the lid (but absence of
peptide). The one outlying feature is the high mobility of
the 30-45 region when p53 is actually binding to MDM2
in approximately the crystallographically observed
mode. While this region is distal to the p53 binding
side, nevertheless the fact that it is high compared to the
equilibrium dynamics [7] suggests that real equilibrium
has not been achieved (this is ok for the purposes of our
current study which only aims to examine the processes
that occur as p53 approaches MDM2). When p53 is
distant from MDM2, Y100 can assume both “in" and
“out" states, with only the “out" state enabling binding.
The binding process requires an initial encounter
complex that is driven by nonspecific forces where
electrostatic steering plays a major role. This is then
accompanied by either the embedding of Phe19 or W23,
that act as anchors across which the other two residues
can be embedded. Both these residues, W23 and L26
require that Y100 is in an “out" conformation. This
would enable the sidechain of W23 to make an HB with
the backbone of L54 (which otherwise makes an HB with
the hydroxyl of Y100). When Y100 is “in", it also
(a) (b)
p53 binding 
pocket 
(c) (d)
Y100
H96
R97
Y100
L54
(e) (f) (g)
Y100
F55
K51
F55
L26
F19
K51
V93
V75
F91
I61
Figure 6
(a) Surface representation of the Model 1 of the NMR ensemble (1Z1M), showing the absence of a well defined
pocket. This conformation has been used to run M1n4A after placing the p53. (b) MDM2 surface is showing an well defined
pocket after simulation in presence of p53 (M1n4A), p53 has not been shown for clarity. (c) Hydrophobic Packing of F19 of
p53 (red) in the binding pocket of MDM2 (green) at the end of 20 ns simulation (M1n4A) and (d) the complex same
conformation with MDM2 in surface representation. Y100 is deeply buried, pointing towards the core of MDM2. (e) shows the
snapshot from M1n4WT at the end of 5 ns simulation, which does not form the HB between W23 and L54; (f),(g) are the
snapshot taken at the end of 10 ns simulation of the trajectory of M1n6A, shown in two different representations.
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Y100 is “in", the C-terminal region of the TA of p53 also
plays a critical role in modulating the dynamics of Y100
by preventing its transition to “open" states (at least in
the timescales of these simulations).
The NMR ensemble shows that the “apo" states of
MDM2 have Y100 “in" [8]. This is to minimize the
exposed hydrophobic surface of the binding pocket.
What is interesting is that these “apo" states, derived
from NMR, had their N-terminal 24 residues (the lid)
removed prior to simulations (in presence of p53 in the
system). If the lid is included in the simulations (in
absence of p53), there are two scenarios (Figure 7 and
Additional Files 9, 10, 11). In some of the structures, the
lid is localized over the binding site and pushes against
Y100 and even during simulations, Y100 remains “in".
However, there are some structures where the lid is
localized away from the binding pocket. Simulations of
these structures show that the restraint of the lid on Y100
is rapidly released and Y100 assumes an “out" con-
formation (Figure 7 and Additional Files 9, 10, 11). The
(a) (b)
Y100
p53 binding 
pocket 
Y100 p53 binding 
pocket 
Lid
(c) (d)
p53 binding 
pocket 
Y100  Y100 
L54 
Lid
Lid
(e) (f)
Figure 7
(a),(b) Snapshot taken at the end of 20 ns simulation of 'apo' state only (Trajectory M1n). Y100 has flipped out. (c),
(d) Snapshot taken at the end of 15 ns simulation of the 'apo' state of MDM2 containing the lid covering the MDM2 surface
(residue 1-119, Trajectory M1n119). Y100 remains in the deeply buried situation and no well defined binding pocket has been
observed. (e), (f) Snapshot taken at the end of 15 ns simulation of the 'apo' state of MDM2 containing the lid but not in contact
with the MDM2 surface. Y100 flips out and well defined binding pocket has been observed. Figures in each row correspond to
same structure but in two different representations: ribbon and surface. Surfaces have been shown for residues 25-109 only.
The lid residues (1-24) have been shown in purple color.
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the absence of p53. This once again highlights the
importance of the restraints that the local environment
places upon the gating of Y100. Y100 in turn modulates
the size of the binding pocket and also controls the local
polarity by releasing the L54 backbone as a potential
hydrogen bonding partner (for W23). Thus this suggests
that a re-organization or induction to “open" and
“closed" from “apo" states may be induced by the lid
(or other factors). These in turn can be modulated by the
presence of p53 and can either directly bind p53 (open
Y100) or when p53 can induce an open state from a
closed state by the conformational dynamics of the
C-terminal end of the TA domain. This starts assuming
significance biologically for several reasons: (a) the
control of the size/polarity of the binding pocket by
Y100 can affect the binding of p53 (and related proteins
such as p73) and small molecules. We have shown how
the orientation of Y100 modulates the thermodynamics
of the peptidic inhibitors [7], a feature also demon-
strated in other computational studies [30,31]; (b) the
increasing importance of theM D M 2l i dr e g i o n ,w h i c hi s
strictly conserved in mammals, in modulating the
binding of p53 [32,33]; it is possible that by gating
the dynamics of Y100, the lid region may influence the
kinetics of binding of p53. The lid is known to compete
only very weakly with peptidic inhibitors of MDM2 [34].
However to our knowledge, there is no published data
available on the kinetics of peptide binding as modu-
lated by the lid region in MDM2. The work of Worall
et al. [33] has shown that the lid dynamics mostly
modulate the ligase activity of the MDM2 which involves
interactions of the lid with a region away from the p53
TA binding N-terminal region. It is clear that there must
be a correlation between lid dynamics and substrate
access as has been also found in several other systems as
lactate dehydrogenase, lipases, adenylate kinases [35] (c)
these questions assume greater significance with recent
observations pointing to the increasingly complex
interactions between MDM2 and p53 [30,31,36,37].
While our findings of the role of Y100 in modulating the
equilibrium dynamics of the complex are in agreement
withthefindingsofothers[30]theaddedinsightsbrought
aboutbyourstudies, i.e.,themodulationofthedynamics
of the peptide and protein even before the binding event
has taken place, is particularly relevant to understanding
theon-ratesofdifferentpeptidesandperhapsmayprovide
insights into the development of peptidic therapeutics
whose rates of binding may be tunable.
Conclusion
Molecular dynamics simulations have revealed how the
binding of p53 to MDM2 is modulated by the
conformational mobility of Y100 which is the gatekeeper
residue in MDM2. They also reveal how the mobility
of this residue itself can be modulated by the conforma-
tions of p53 and by the conformations of the Nterminal
lid region of MDM2.
Methods
The 'open' state of MDM2 (residues 25-109) was
obtained from the crystal structure of the MDM2-p53
complex (RCSB entry 1YCR, resolved at 2.6 Å) [10]. The
'closed' state of MDM2 (residues 25-109) was obtained
from our previous work [7]. The structure of the 'apo'
state was chosen as Model 1 of the NMR ensemble [8]
and although this structure consists of residues 1-119, we
chose only residues 25-109 to be consistent with
the other structures of MDM2 that have been used in
the current and previous work. In order to examine the
dynamics of the approach of p53 and MDM2 towards
each other, we carry out all-atom simulations with
MDM2 and p53 separated by varying distances (Table 1).
We have also carried out simulations of MDM2 alone
with its N-terminal 1-24 residues included as well. The
C H A R M M 2 2f o r c ef i e l d[ 3 8 ]w a su s e dt or e p r e s e n tt h e
systems. Each system was solvated using TIP3P water
moleculesandneutralizedusingcounter-ionsasrequired.
After brief energy minimizations, each system was heated
to 300 K followed by equilibration under constant
pressure and temperature. Then molecular dynamics
(MD) simulations at constant temperature and volume
were carried out on each system for periods varying
between 5-40 ns, yielding a total sampling time of ~200
ns. SHAKE [39] was applied to freeze the vibration of
bonds involving hydrogen atoms, thus enabling a 2fs
integration time step to be used. The Berendsen thermo-
stat [40] was applied to keep the temperature constant.
Simulations were carried out using the CHARMM
package. Enthalpy was calculated using the MMGBSA
approximations, with the GBSW [41,42] implicit solvent
model. Figures were prepared using PYMOL [43] and
movies were generated using VMD [44].
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Additional material
Additional file 1
PDF format contains RMSD plots, average fluctuations, information of
sampling of key side chain dihedrals etc.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S1.pdf]
Additional file 2
Movie file of Trajectory Mo3A, red ribbon represents p53 and green
ribbon represents MDM2. Few important side chains have been shown
in 'sticks'. H-bonds appear as dashed lines.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S2.zip]
Additional file 3
Movie file of Trajectory Mc3AT1, coloring scheme is same as M1, The
surface representation of this movie is available at http://web.bii.a-star.
edu.sg/~shubhragd/paper_movies
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S3.zip]
Additional file 4
Movie file, Trajectory Mc3AT2, shows the conformational transition of
Y100 and p53 binding. The same movie but having MDM2 in 'surface'
representation is available at http://web.bii.a-star.edu.sg/~shubhragd/
paper_movies/
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S4.zip]
Additional file 5
Movie file, Trajectory Mc6A.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S5.zip]
Additional file 6
Movie file, Trajectory Mc6A, side view
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S6.zip]
Additional file 7
Movie file, Trajectory M1n4A7ns
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S7.zip]
Additional file 8
Movie file, Trajectory M1n4A
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S8.zip]
Additional file 9
Movie file, Trajectory M1n, showing dynamics of Model 1 of NMR
ensemble after deletion of residues outside the range of 25-109. The
conformational change of Y100 side chains is observed.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S9.zip]
Additional file 10
Movie file, Trajectory M2n119. Shows the dynamics of MDM2 when
the lid is close to the binding pocket. The Y100 has been shown in purple
color for clarity. The Movie shows that Y100 stays in a deeply buried
state when the lid is present.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S10.zip]
Additional file 11
Movie file, Trajectory M4n119. Shows the dynamics of MDM2 when
the lid is away from the binding pocket. Y100 flips and points away from
the binding pocket.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-S15-S6-S11.zip]
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